ETON
Eton Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$41.07-2.95%
Price as of Jul 20, 2026
ETON valuation
Eton Pharmaceuticals, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 32.99x
- P/E 2026E
- 40.22x
- P/E 2027E
- 25.36x
- P/E 2028E
- 18.36x
- P/S forward
- 9.94x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 36.75x
- Price / sales
- 12.94x
- Price / cash flow
- 71.03x
Enterprise value
- Enterprise value
- $1.1B
- EV / sales
- 12.86x
- EV / EBITDA
- 204.91x
- EV / EBIT
- 547.84x
- Market cap
- $1.1B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.